Business
Extendicare Announces 2025 Fourth Quarter and Full Year Results and Dividend Increase
MARKHAM, Ontario, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and twelve months ended December 31, 2025. Fourth Quarter 2025 Highlights Adjusted EBITDA(1), excluding out-of-period items, increased by $12.2 million or 36.4% from Q4 2024 to $45.6 million, driven primarily by continued organic growth in the home health care segment and contributions from the acquisition of nine Class C LTC homes and Closing the
About this update from Extendicare Inc.
[{"type":"image","alt":"Extendicare Inc.","displaySize":"","headline":null,"caption":"Extendicare Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":63,"url":"https://media.zenfs.com/en/globenewswire.com/f8d74dab7b45a9e5f64799c7017605c8"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/4DCgQHrSxLiL11NW5cA.AA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTg4O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/f8d74dab7b45a9e5f64799c7017605c8","width":300,"height":63}},"lazy":false},{"type":"text","content":"MARKHAM, Ontario, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and twelve months ended December 31, 2025.","length":192,"tagName":"p"},{"type":"text","content":"Fourth Quarter 2025 Highlights","length":30,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Adjusted EBITDA(1), excluding out-of-period items, increased by $12.2 million or 36.4% from Q4 2024 to $45.6 million, driven primarily by continued organic growth in the home health care segment and contributions from the acquisition of nine Class C LTC homes and Closing the Gap.","length":280,"tagName":"p"}]},{"val":[{"type":"text","content":"Home health care average daily volume (“ADV”) increased by 8,447 or 27.3% from Q4 2024 to 39,440, including ADV of 3,700 from Closing the Gap.","length":142,"tagName":"p"}]},{"val":[{"type":"text","content":"Third-party and joint venture beds serviced by SGP reached 153,600 beds, reflecting organic growth of 5.0% from Q4 2024.","length":120,"tagName":"p"}]},{"val":[{"type":"text","content":"As previously announced, the Company has entered into a definitive agreement to acquire CBI Home Health for $570.0 million, subject to customary adjustments and closing conditions.","length":180,"tagName":"p"}]},{"val":[{"type":"text","content":"Completed a private placement issuance of 10,640,000 common shares in December 2025, raising $191.5 million, net of costs, to partially fund the acquisition of CBI Home Health.","length":176,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":898,"olType":false},{"type":"text","content":"Subsequent to Q4","length":16,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Announced a 5% increase to its monthly dividend to 4.41 cents per common share.","length":79,"t...